Tower Research Capital (TRC)’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Sell |
33,890
-6,586
| -16% | -$76.3K | 0.01% | 1183 |
|
|
2025
Q1 | $356K | Buy |
40,476
+9,712
| +32% | +$85.5K | 0.01% | 1044 |
|
|
2024
Q4 | $442K | Buy |
30,764
+26,565
| +633% | +$381K | 0.01% | 1156 |
|
|
2024
Q3 | $94.8K | Buy |
4,199
+977
| +30% | +$22.1K | ﹤0.01% | 2277 |
|
|
2024
Q2 | $62.7K | Sell |
3,222
-1,564
| -33% | -$30.4K | ﹤0.01% | 2925 |
|
|
2024
Q1 | $180K | Buy |
4,786
+1,636
| +52% | +$61.4K | ﹤0.01% | 1478 |
|
|
2023
Q4 | $176K | Buy |
3,150
+446
| +16% | +$25K | ﹤0.01% | 2204 |
|
|
2023
Q3 | $112K | Sell |
2,704
-4,058
| -60% | -$167K | ﹤0.01% | 1908 |
|
|
2023
Q2 | $378K | Buy |
6,762
+4
| +0.1% | +$223 | 0.01% | 1143 |
|
|
2023
Q1 | $377K | Buy |
6,758
+3,856
| +133% | +$215K | 0.01% | 1005 |
|
|
2022
Q4 | $106K | Sell |
2,902
-16,445
| -85% | -$601K | ﹤0.01% | 1793 |
|
|
2022
Q3 | $551K | Buy |
19,347
+1,949
| +11% | +$55.5K | 0.01% | 1066 |
|
|
2022
Q2 | $788K | Buy |
17,398
+9,741
| +127% | +$441K | 0.02% | 835 |
|
|
2022
Q1 | $583K | Buy |
7,657
+3,620
| +90% | +$276K | 0.01% | 1070 |
|
|
2021
Q4 | $602K | Buy |
4,037
+1,422
| +54% | +$212K | 0.01% | 991 |
|
|
2021
Q3 | $380K | Sell |
2,615
-11,658
| -82% | -$1.69M | 0.01% | 1188 |
|
|
2021
Q2 | $2.8M | Sell |
14,273
-1,452
| -9% | -$284K | 0.07% | 209 |
|
|
2021
Q1 | $2.85M | Buy |
15,725
+12,179
| +343% | +$2.2M | 0.05% | 363 |
|
|
2020
Q4 | $502K | Buy |
3,546
+3,311
| +1,409% | +$469K | 0.02% | 989 |
|
|
2020
Q3 | $29K | Sell |
235
-648
| -73% | -$80K | ﹤0.01% | 3737 |
|
|
2020
Q2 | $79K | Buy |
+883
| New | +$79K | ﹤0.01% | 2662 |
|
|
2020
Q1 | – | Sell |
-5,263
| Closed | -$401K | – | 3907 |
|
|
2019
Q4 | $401K | Buy |
5,263
+311
| +6% | +$23.7K | 0.03% | 343 |
|
|
2019
Q3 | $250K | Buy |
+4,952
| New | +$250K | 0.02% | 892 |
|